Published in Women's Health Weekly, November 3rd, 1997
Hyal Pharmaceutical is contributing over $1 million over three years to support this research; NSERC is contributing $490,000 over the same period.
Dr. Winnik and her co-workers will study the use of hyaluronic acid (HA) in conjunction with magnetic resonance imaging (MRI) in mammography to better detect breast cancer in its early stages....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.